Social media influencers in Maharashtra who promote protein powders and health supplements through misleading advertisements could face penalties of up to ₹10 lakh, with the state Food and Drug Administration tightening scrutiny of the sector. FDA Commissioner Tukaram Mundhe has issued a statewide compliance order covering health supplements, nutraceuticals and special dietary foods, effective immediately and applying to manufacturers, importers, distributors, retailers, pharmacies, gyms and e-commerce platforms.

The order bars advertisements claiming such products can treat, cure, mitigate or prevent diseases, as well as promotional material stating products are "recommended by doctors or nutritionists", carrying photographs of physicians or claiming clinical prescription. The penalty for misleading advertisements is separate from the existing penalty of up to ₹10 lakh for running a food business without the required licence. Businesses making or selling these products must hold the relevant FSSAI licence with the specific food category endorsed, and pharmacies and gyms selling them must obtain a food licence or registration even if they hold licences under other laws. Enforcement targets sports nutrition, weight-loss, sexual-wellness and herbal products over suspicions of undeclared steroids and other drug substances.

The FDA said inspections on November 13 found manufacturers using Magnesium Acetyl Taurate and Nicotinamide Mononucleotide, ingredients whose product approval applications had been rejected by the FSSAI. Stock worth ₹1,38,95,852 was seized from 17 establishments across six divisions, with samples sent for laboratory analysis on suspicion the products were substandard, unsafe and misbranded; further legal action will follow the food analyst's report. Nagpur recorded the highest seizure at ₹57.30 lakh, followed by Konkan at ₹47.65 lakh and Pune at ₹30.57 lakh, while Nashik saw ₹1.99 lakh and Chhatrapati Sambhajinagar ₹1.42 lakh; no seizure was reported in Amravati.

The order requires manufacturers to declare the specific plant part used in every botanical ingredient and carry prescribed label warnings, permitting only roots and root extracts of Ashwagandha, and prohibits use of the term "ORS" in product, brand or trademark names. It covers 1,100 existing licence holders in the health supplement and nutraceutical categories, including 313 manufacturers, 759 relabellers and 28 repackers. The department plans further risk-based inspections prioritising sports nutrition, weight-loss, sexual-wellness, herbal and imported products, with online sales and hospital-supplied products also under scrutiny. Violations could invite improvement notices, suspension or cancellation of licences, product seizures, recalls and criminal proceedings.